Finance

Lists
Why is SBFM down 5,28%?
Dive Deeper
SBFM:NASDAQ
Sunshine Biopharma Inc
0,40 $
-5,28%
(-0,022) 1D
0,41 $
+2,97% (+0,012)
After hours
Closed: 6 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBFM...
Open
0,43 $
High
0,43 $
Low
0,36 $
Mkt. cap
2,72 млн
Avg. vol.
559,46 м.
Volume
4,52 млн
52-wk high
24,30 $
52-wk low
0,36 $
EPS
-10,03 $
Beta
1,35
Shares outstanding
4,31 млн
No. of employees
50
Open
0,43 $
High
0,43 $
Low
0,36 $
Mkt. cap
2,72 млн
Avg. vol.
559,46 м.
Volume
4,52 млн
52-wk high
24,30 $
52-wk low
0,36 $
EPS
-10,03 $
Beta
1,35
Shares outstanding
4,31 млн
No. of employees
50
News stories
From web sources and news partners
About Sunshine Biopharma Inc
CEO-
Employees50
Founded2006
HeadquartersФорт-Лодердейл, Флорида, Америка Құрама Штаттары
Sector-
Websitesunshinebiopharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
9,42 млн
8,58 млн
8,09 млн
9,26 млн
Cost of goods sold
6,34 млн
5,55 млн
5,91 млн
6,84 млн
Cost of revenue
6,34 млн
5,55 млн
5,91 млн
6,84 млн
Research and development expenses
119,30 м.
73,50 мың
31,72 мың
13,22 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,27 млн
4,39 млн
3,34 млн
3,81 млн
Operating expense
3,61 млн
4,69 млн
3,58 млн
4,04 млн
Total operating expenses
9,95 млн
10,24 млн
9,48 млн
10,88 млн
Operating income
-531,96 м.
-1,66 млн
-1,40 млн
-1,61 млн
Other non operating income
-
-
103,32 м.
-
EBT including unusual items
-1,02 млн
-1,73 млн
-1,24 млн
-1,56 млн
EBT excluding unusual items
-456,36 м.
-1,60 млн
-1,24 млн
-1,56 млн
Income tax expense
-137,44 м.
408,37 м.
-
-
Effective tax rate
13,46%
-23,57%
-
-
Other operating expenses
119,91 м.
126,54 м.
129,66 м.
138,49 м.
Net income
-883,82 м.
-2,14 млн
-1,24 млн
-1,56 млн
Net profit margin
-9,39%
-24,96%
-15,38%
-16,88%
Earnings per share
-
-
-
-
Interest and investment income
75,35 мың
57,47 мың
48,43 мың
48,82 мың
Interest expense
-
-
-
-
Net interest expenses
75,35 мың
57,47 мың
48,43 мың
48,82 мың
Depreciation and amortization charges
95,82 мың
98,92 мың
76,86 мың
77,97 мың
EBITDA
-435,80 м.
-1,56 млн
-1,32 млн
-1,53 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары